The global medical device CDMO market size was estimated at USD 122.6 billion in 2024 and is projected to reach USD 354.6 billion by 2033, growing at a CAGR of 12.87% from 2025 to 2033. The market expansion is primarily driven by the increasing trend of outsourcing manufacturing activities, rising cost pressures on medical device companies, and the growing need for specialized expertise in developing and producing advanced medical devices.

Many manufacturers are increasingly partnering with CDMOs to optimize their production processes, reduce time-to-market, and access sophisticated manufacturing capabilities without the substantial financial investment required to build or upgrade in-house facilities. This approach allows companies to focus on innovation, product development, and regulatory compliance, while relying on CDMOs for efficient and scalable production. The demand for medical devices is further fueled by global demographic shifts, including an aging population, the rising prevalence of chronic diseases, and a growing preference for home care and minimally invasive treatment options. These factors are encouraging medtech companies, both established and emerging, to leverage outsourcing as a strategic advantage in a competitive and evolving industry.

The market is also gaining momentum due to ongoing technological advancements that enhance production efficiency and competitiveness. The integration of digital manufacturing technologies, automation, and advanced materials into production workflows has improved precision, scalability, and regulatory compliance, supporting faster and more reliable manufacturing processes. Additionally, the rise of additive manufacturing, particularly 3D printing, has enabled rapid prototyping, accelerated product development, and the creation of customized and patient-specific medical device solutions. These technological innovations are further strengthening the role of CDMOs in meeting the growing and increasingly complex demand for medical devices worldwide.

Key Market Trends & Insights:

• In 2024, the North America medical device Contract Development and Manufacturing Organization (CDMO) market held the largest share of the global market, accounting for 48.40%. The region’s leadership is driven by the presence of a highly developed healthcare infrastructure, strong adoption of outsourcing strategies by medical device manufacturers, and the concentration of leading CDMO service providers in the United States and Canada. These factors collectively contribute to North America’s dominant position in the global market.

• Within the region, the U.S. market for medical device CDMOs is expected to experience significant growth over the forecast period. This expansion is supported by increasing demand for specialized manufacturing capabilities, technological advancements, and the growing need for efficient and cost-effective production solutions in the face of rising regulatory and operational complexities in the medical device industry.

• Based on product type, the therapeutics segment held the highest market share in 2024. The strong performance of this segment can be attributed to the growing demand for therapeutic medical devices, including drug-delivery systems, implants, and other advanced therapeutic technologies that require precise and reliable manufacturing processes.

• In terms of service type, the contract manufacturing segment accounted for the largest market share in 2024. This reflects the increasing reliance of medical device companies on CDMOs to handle manufacturing operations, enabling manufacturers to focus on product development, regulatory compliance, and market expansion while leveraging the expertise and infrastructure of specialized service providers.

• By device class, the class III segment held the highest market share in 2024. Class III medical devices, which include high-risk devices such as cardiac implants, neurosurgical devices, and other critical therapeutic devices, require stringent manufacturing standards, advanced technologies, and specialized expertise. The dominance of this segment underscores the importance of CDMOs in providing high-quality production solutions for complex and high-risk medical devices.

Order a free sample PDF of the Medical Device CDMO Market Intelligence Study, published by Grand View Research.

Market Size & Forecast:

• 2024 Market Size: USD 122.6 Billion

• 2033 Projected Market Size: USD 354.6 Billion

• CAGR (2025-2033): 12.87%

• North America: Largest market in 2024

Key Companies & Market Share Insights:

Key players operating in the global medical device CDMO market are actively implementing a variety of strategic initiatives to strengthen their market positions and gain a competitive edge. These initiatives include launching new services, pursuing mergers and acquisitions, forming partnerships and agreements, and expanding operational footprints. Such strategies allow companies to enhance their capabilities, broaden their product and service offerings, and better address the evolving needs of medical device manufacturers.

For example, in October 2024, Biomerics announced the launch of its new metal injection molding (MIM) services. This strategic launch is aimed at reinforcing the company’s focus on contract design and advanced metals manufacturing, positioning Biomerics to better serve clients requiring specialized solutions. By integrating these new MIM services with its well-established expertise in micro metals processing, the company’s Micro Metals Division is expected to significantly enhance its capabilities. This expansion will enable Biomerics to deliver highly complex, high-precision interventional devices and components, meeting the increasing demand for sophisticated medical device manufacturing solutions in the industry.

Key Players

• Jabil Inc.

• Thermo Fisher Scientific Inc.

• Integer Holdings Corporation

• FLEX Ltd.

• Sanmina Corporation

• Celestica Inc.

• Phillips-Medisize

• Plexus Corp.

• Nipro Corporation

• Viant Technology LLC

• West Pharmaceutical Services, Inc.

• Mack Molding

• Cirtec Medical

• Cogmedix

• Synecco Ltd.

• TE Connectivity

• Keller Technology Corp.

• HDA Technology, Inc.

Explore Horizon Databook – The world's most expansive market intelligence platform developed by Grand View Research.

Conclusion:

The global medical device CDMO market is set for substantial growth as more medical technology companies increasingly outsource key functions like design, development, and manufacturing to specialized partners. This trend is driven by the need to reduce costs, accelerate time to market, and gain access to advanced manufacturing capabilities without large capital investments. Technological progress, including digital manufacturing, automation, and 3D printing, is enhancing production precision and efficiency, while evolving healthcare demands—such as aging populations and chronic diseases—are further boosting demand for outsourced medical device manufacturing. As a result, CDMOs are becoming essential partners in the development and commercialization of innovative medical technologies across various device categories.